IDEAYA Biosciences, Inc.
IDYA · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | – | $1,860 | $1,447 | $2,245 |
| - Cash | $299 | $115 | $130 | $84 |
| + Debt | $27 | $27 | $26 | $19 |
| Enterprise Value | – | $1,772 | $1,343 | $2,179 |
| Revenue | $208 | $0 | $0 | $7 |
| % Growth | – | – | -100% | – |
| Gross Profit | $207 | -$1 | -$1 | $6 |
| % Margin | 99.5% | – | – | 90.8% |
| EBITDA | $120 | -$76 | -$71 | -$130 |
| % Margin | 57.9% | – | – | -1,852.4% |
| Net Income | $119 | -$77 | -$72 | -$130 |
| % Margin | 57.4% | – | – | -1,861.6% |
| EPS Diluted | 1.33 | -0.88 | -0.82 | -1.49 |
| % Growth | 251.1% | -7.3% | 45% | – |
| Operating Cash Flow | $142 | -$62 | -$60 | -$122 |
| Capital Expenditures | -$0 | -$1 | -$1 | -$1 |
| Free Cash Flow | $142 | -$63 | -$62 | -$123 |